Evidence map›Paper›PMID 31911460›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2020

Blocking the Thrombin Receptor Promotes Repair of Demyelinated Lesions in the Adult Brain.

Hyesook Yoon, Chan-Il Choi, Erin M Triplet, Monica R Langley, Laurel S Kleppe, Ha Neui Kim, Whitney L Simon, Isobel A Scarisbrick

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Regional Molecular Diversity in Chronic Spinal Cord Injury.Cellular and molecular neurobiology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Endothelial protease-activated receptor 4: impotent or important?Frontiers in cardiovascular medicine · 2025
    Review
  6. Article
  7. Astrocytes: Lessons Learned from the Cuprizone Model.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Critical Role of Astrocyte NADThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Hyesook YoonDepartment of Physical Medicine and Rehabilitation, Rehabilitation Medicine Research Center.
Chan-Il ChoiDepartment of Physical Medicine and Rehabilitation, Rehabilitation Medicine Research Center.
Erin M TripletNeuroscience Program, and.ORCID 0000-0002-5303-4576
Monica R LangleyDepartment of Physical Medicine and Rehabilitation, Rehabilitation Medicine Research Center.
Laurel S KleppeDepartment of Physical Medicine and Rehabilitation, Rehabilitation Medicine Research Center.
Ha Neui KimDepartment of Physical Medicine and Rehabilitation, Rehabilitation Medicine Research Center.
Whitney L SimonDepartment of Physical Medicine and Rehabilitation, Rehabilitation Medicine Research Center.
Isobel A ScarisbrickDepartment of Physical Medicine and Rehabilitation, Rehabilitation Medicine Research Center, Scarisbrick.Isobel@mayo.edu.ORCID 0000-0003-2395-589X
Rehabilitation Research and Development Service · USSociety for Neuroscience · US

Funding

Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
Role of Protease Activated Receptors in Spinal Cord Injury and RepairR01NS052741 · NINDS · MAYO CLINIC ROCHESTER · PI SCARISBRICK, ISOBEL A · 2008 to 2017
$3.6M
Regulatory Action of Protease Activated Receptor 1 in Myelin ProductionR21NS107946 · NINDS · MAYO CLINIC ROCHESTER · PI SCARISBRICK, ISOBEL A · 2019 to 2019
$437k
NIGMS NIH HHS T32 GM065841NINDS NIH HHS R01 NS052741NINDS NIH HHS R21 NS107946
6 · The paper itself

Abstract

Myelin loss limits neurological recovery and myelin regeneration and is critical for restoration of function. We recently discovered that global knock-out of the thrombin receptor, also known as Protease Activated Receptor 1 (PAR1), accelerates myelin development. Here we demonstrate that knocking out PAR1 also promotes myelin regeneration. Outcomes in two unique models of myelin injury and repair, that is lysolecithin or cuprizone-mediated demyelination, showed that PAR1 knock-out in male mice improves replenishment of myelinating cells and remyelinated nerve fibers and slows early axon damage. Improvements in myelin regeneration in PAR1 knock-out mice occurred in tandem with a skewing of reactive astrocyte signatures toward a prorepair phenotype. In cell culture, the promyelinating effects of PAR1 loss of function are consistent with possible direct effects on the myelinating potential of oligodendrocyte progenitor cells (OPCs), in addition to OPC-indirect effects involving enhanced astrocyte expression of promyelinating factors, such as BDNF. These findings highlight previously unrecognized roles of PAR1 in myelin regeneration, including integrated actions across the oligodendrocyte and astroglial compartments that are at least partially mechanistically linked to the powerful BDNF-TrkB neurotrophic signaling system. Altogether, findings suggest PAR1 may be a therapeutically tractable target for demyelinating disorders of the CNS.

Indexed as

Platelet Aggregation InhibitorsAnimalsAstrocytesAxonsBrain-Derived Neurotrophic FactorChelating AgentsCoculture TechniquesCopperCorpus CallosumCuprizoneDemyelinating DiseasesGene Expression ProfilingLysophosphatidylcholinesMaleMiceMice, KnockoutBdnf protein, mouseBrain-Derived Neurotrophic FactorChelating AgentsCopperCuprizoneLysophosphatidylcholinesPlatelet Aggregation InhibitorsReceptor, PAR-1astrocytebrain derived neurotrophic factormyelinoligodendrocyte progenitor cellsprotease activated receptorregeneration

Identifiers

PMID31911460
PMCPMC7044736
OpenAlexW3000553404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.